![]() ![]() #healthcare #medicine #ai #artificialintelligence #generativeai DMs are open if you're interested in submitting a publication! You can also submit manuscripts for future issues via the website. insurance claims showed limited but growing adoption of medical AI devices, predominantly in wealthier, urban areas, highlighting the need for broader access and integration of AI in healthcare. Characterizing the Clinical Adoption of Medical AI Devices through U.S. Development Pipeline and Geographic Representation of Trials for Artificial Intelligence/Machine Learning-Enabled Medical Devices (2010 to 2023): A study of clinical trials for AI/ML-enabled medical devices showed a concentration in certain specialties and countries, emphasizing the need for more diverse and international trials. High-Impact Medical Journals Reflect Negative Sentiment Toward Psychiatry: Analysis of high-impact medical journal articles revealed a higher negative sentiment towards psychiatry compared to other specialties, indicating possible bias and calling for further exploration of its causes and impacts. Use of GPT-4 to Diagnose Complex Clinical Cases: GPT-4 diagnosed 57% of complex medical cases, outperforming 99.98% of simulated human readers, suggesting its potential as a diagnostic tool, though further development and ethical considerations are necessary. The journal will identify and evaluate state-of-the-art applications of artificial intelligence to clinical medicine by collaborating across computer science, AI, policy, ethics, and biomedical disciplines.īetween now and the official launch, we'll be sharing early release articles here: Ĭurrent early release publications cover a broad range of topics: NEJM AI is a new journal from the NEJM Group that will be published in January 2024. New early release articles from the New England Journal Artificial Intelligence ( NEJM AI) journal! #healthcare #ai #artificialintelligence #lifesciences #biotechīioByte 057: Why invest in biotech, astrocytes in neuroinflammation, comp bio for novel CRISPR variants, life-extension drugs nearing approval Biotech SaaS Business Models: The emergence of companies like Cradle, which offers web-based software for AI protein design, highlights new opportunities for category creation in biotech SaaS. Astrocytes in Neuroinflammation: Recent research highlights the critical role of astrocytes in neurodegenerative diseases, underscoring their potential as targets for new therapeutic approaches in conditions like Alzheimer’s and Parkinson’s. CRISPR-Cas Systems Discovery: A new method developed for deep terascale clustering authored by Feng Zhang’s lab has led to the discovery of 188 new CRISPR-linked gene modules, demonstrating a breakthrough in efficiently analyzing massive genetic datasets. Life-Extension Drug for Dogs: Biotech company Loyal / Cellular Longevity received FDA approval for a drug that potentially extends canine lifespan by altering growth hormone levels, with plans for larger trials following successful preliminary tests. Latent Optima in Biology: Alex Telford's essay explores how latent information, a key concept in machine learning, can be applied to biology as a tool for generating optimization functions validated by natural selection. This LGBTQ health startup just passed a major milestone-insurance coverage #healthcare #healthequity #LGBTQ #primarycare Kate Steinle Brad Nations, MSHCT Ryan Scharer and the entire FOLX team on this achievement. If you're a health plan interested in how you might partner with FOLX, please reach out! ![]() With insurance reimbursement, FOLX is expanding access to life-saving care on a national scale. Integral to achieving health equity is meeting members where they are - clinically, socioeconomically, and in community - with expert, specialty services. Congratulations to the FOLX Health team on this remarkable milestone - securing insurance coverage with several leading national and state health plans including Cigna Healthcare, Evernorth Health Services, and Blue Shield of California - as a national provider of LGBTQ+ care, with several fast-followers to be announced soon.Īt such a critical time for the LGBTQ+ community from a legislative perspective, these organizations are doubling down on their support and investment in this immensely underserved population with unmet medical needs. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |